Skip to content

Clinical trials

Phase 2 Esophageal Squamous Cell Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 2 Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20111
20121
20151
20172
20181
20192
20214
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center5
Yonsei University3
BeiGene2
AstraZeneca1
Bayer1
Hoffmann-La Roche1
Sanofi1
Seagen Inc.1
Sung Yong Oh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma16
Squamous Cell Carcinoma of Head and Neck3
Esophageal Neoplasms2
Astrocytoma1
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Glioblastoma1
Melanoma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.